Nasopharyngeal Undifferentiated Carcinoma

Nasopharyngeal Undifferentiated Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00274937	Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer	completed	Phase 3	111	Children's Oncology GroupNETWORK	3	Oct 25, 2022	clinicaltrials

Data updated 23 days agoSource updated Oct 25, 2022source: clinicaltrials